Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab

医学 内科学 曲妥珠单抗 免疫组织化学 肿瘤科 队列 胃肠病学 癌症 外科肿瘤学 乳腺癌
作者
Kyunghye Bang,Jaekyung Cheon,Young Soo Park,Hyung‐Don Kim,Min‐Hee Ryu,Yangsoon Park,Meesun Moon,Hyungeun Lee,Yoon‐Koo Kang
出处
期刊:Gastric Cancer [Springer Nature]
卷期号:25 (4): 794-803 被引量:17
标识
DOI:10.1007/s10120-022-01298-6
摘要

The GASTHER1 study showed that re-evaluation of HER2 status rescued 8% of HER2-positive gastric cancer (GC) patients with initially HER2-negative GC. Since rescued HER2 positivity represents HER2 heterogeneity, we aimed to investigate this in a larger cohort with longer follow-up duration.Data of 153 HER2-positive advanced GC patients who received first-line trastuzumab-based chemotherapy were analyzed. Repeat endoscopic biopsy was performed in patients with initially HER2-negative GC. Survival outcomes were analyzed according to the immunohistochemistry (IHC) score (IHC 2+ /in situ hybridization [ISH] + vs IHC 3+), HER2 status (initially vs rescued HER2 positive), and H-score.IHC 2+ /ISH + patients showed worse progression-free survival (PFS) and overall survival (OS) than those with IHC 3+ (p < 0.05). Rescued HER2-positive patients showed worse PFS and OS than initially HER2-positive patients (p < 0.05). Although survival outcomes were comparable according to HER2 status in IHC 2+ /ISH + patients, initially HER2-positive patients showed more favorable PFS and OS than rescued HER2-positive patients (p < 0.05) among those with IHC 3+ . Among the subgroups determined by HER2 status and IHC score, the initially IHC 3+ subgroup had the highest H-score. The low H-score group (H-score ≤ 210) had significantly worse survival outcomes than the high H-score group (H-score > 210) (p < 0.05). An H-score of ≤ 210 was independently associated with shorter OS (HR = 1.54, 95% CI 1.02-2.31, p = 0.04).Rescued HER2-positive patients showed worse clinical outcomes than initially HER2-positive patients, especially those with IHC 3+ . This finding highlights the impact of HER2 heterogeneity, which can be quantified indirectly as an H-score.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kuku完成签到 ,获得积分10
1秒前
1秒前
1秒前
无敌葡萄爱学习完成签到,获得积分10
1秒前
2秒前
jane完成签到 ,获得积分10
2秒前
Lucas应助shania采纳,获得10
3秒前
顾矜应助脊柱发芽采纳,获得10
4秒前
tt耶发布了新的文献求助30
4秒前
Senna完成签到,获得积分10
4秒前
huahua完成签到,获得积分10
5秒前
帅气的马里奥完成签到 ,获得积分10
5秒前
5秒前
花朝唯完成签到 ,获得积分10
5秒前
7秒前
科研通AI2S应助秀丽的千山采纳,获得10
7秒前
小蘑菇应助体贴向珊采纳,获得30
8秒前
可爱的函函应助体贴向珊采纳,获得10
8秒前
脑洞疼应助huahua采纳,获得10
9秒前
忧郁依霜完成签到,获得积分10
11秒前
11秒前
黄小倩发布了新的文献求助10
11秒前
活泼人生完成签到 ,获得积分10
11秒前
瓷儿发布了新的文献求助10
11秒前
zwqxm发布了新的文献求助10
12秒前
12秒前
美好乐松应助快乐抽屉采纳,获得10
16秒前
七月完成签到,获得积分10
17秒前
18秒前
shania发布了新的文献求助10
18秒前
闫思伟完成签到,获得积分20
18秒前
18秒前
共享精神应助基一啊佳采纳,获得10
20秒前
biocreater完成签到,获得积分10
21秒前
科研通AI2S应助WendyWen采纳,获得10
22秒前
Ultraviolet发布了新的文献求助10
23秒前
palu发布了新的文献求助10
23秒前
俊逸湘发布了新的文献求助10
23秒前
刘阳完成签到,获得积分10
24秒前
不配.应助安宁采纳,获得10
25秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
Aspects of Babylonian celestial divination: the lunar eclipse tablets of Enūma Anu Enlil 500
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
2024 Medicinal Chemistry Reviews 400
Dictionary of socialism 350
Mixed-anion Compounds 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3198050
求助须知:如何正确求助?哪些是违规求助? 2847013
关于积分的说明 8061681
捐赠科研通 2511915
什么是DOI,文献DOI怎么找? 1343778
科研通“疑难数据库(出版商)”最低求助积分说明 639624
邀请新用户注册赠送积分活动 609261